Design Therapeutics, Inc. · NASDAQ:DSGN

Point72 Asset Management, L.P.'s stake in Design Therapeutics, Inc. fell to 4.40% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Point72 Asset Management, L.P.'s stake in Design Therapeutics, Inc. fell to 4.40%, 2,722,754 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
4.40%
Shares
2,722,754
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.4.40%2,722,754
Point72 Capital Advisors, Inc.4.40%2,722,754
Steven A. Cohen4.40%2,722,754

Source

View original at SEC

Related